Evidence map›Paper›PMID 40868032›Full record

ArticleAntibiotics (Basel, Switzerland)2025

In Vitro and In Vivo Characterization of Novel Cathelicidin-Based Peptides with Antimicrobial Activity Against

Javier Moreno-Morales, Núria Martín-Vilardell, Salvador Guardiola, Xavier Vila-Farrés, Tania Cebrero, Marko Babić, Clara Ballesté-Delpierre, Daniela Kalafatović, Ernest Giralt, María Eugenia Pachón-Ibañez and 1 more

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Javier Moreno-MoralesBarcelona Institute for Global Health (ISGlobal), 08036 Barcelona, Spain.ORCID 0000-0002-5251-8579
Núria Martín-VilardellBarcelona Institute for Global Health (ISGlobal), 08036 Barcelona, Spain.ORCID 0000-0002-7911-2085
Salvador GuardiolaInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.ORCID 0000-0003-2644-1659
Xavier Vila-FarrésBarcelona Institute for Global Health (ISGlobal), 08036 Barcelona, Spain.
Tania CebreroInstitute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/Spanish National Research Council (CSIC)/University of Seville, 41013 Seville, Spain.ORCID 0000-0001-8221-0965
Marko BabićUniversity of Rijeka, Faculty of Engineering, 51000 Rijeka, Croatia.ORCID 0000-0003-2300-8825
Clara Ballesté-DelpierreBarcelona Institute for Global Health (ISGlobal), 08036 Barcelona, Spain.
Daniela KalafatovićUniversity of Rijeka, Faculty of Engineering, 51000 Rijeka, Croatia.ORCID 0000-0002-9685-1162
Ernest GiraltInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.
María Eugenia Pachón-IbañezInstitute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/Spanish National Research Council (CSIC)/University of Seville, 41013 Seville, Spain.ORCID 0000-0001-7969-8162
Jordi VilaBarcelona Institute for Global Health (ISGlobal), 08036 Barcelona, Spain.ORCID 0000-0002-8025-3926

Funding

Generalitat de Catalunya 2021SGR01569Instituto de Salud Carlos III PI20/00766MINECO (Spanish Government) CEX2018-000806-S
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AMRantimicrobial peptidesbactericidalCAP-18novel antibiotics

Identifiers

PMID40868032
PMCPMC12382740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.